|
LXRX | Lexicon Pharmaceuticals, Inc. |
|
|
LXRX | Lexicon Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.37 |
| Leverage | 41.65% |
| Market Cap | $ 320.9m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -68.8m |
| Margin | -87.18% |
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.